Yanyan Shi – Trademark Portfolio

Entity Type: 01

Yanyan Shi holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 4 filings in this category. The portfolio also extends into Class 18 (Leather Goods) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include IEMATOZ, REAMPHY, and TSMNZMU. The owner is based in Baoji,Shaanxi.

No.601,Unit 3,Building 14,No.49

Xibao Road,Weibin District

Baoji,Shaanxi 721000 , CN

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

IEMATOZ
IEMATOZ
Registered 2018
REAMPHY
REAMPHY
Registered 2018
TSMNZMU
TSMNZMU
Registered 2018
KIMDYSU
KIMDYSU
Cancelled 2018
EACIECK
EACIECK
Cancelled 2018
TOUTOU
TOUTOU
Pending 2018

Trademark Classifications

Yanyan Shi's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (4 filings)

Clothing, footwear, headgear

18
Leather Goods (3 filings)

Leather and imitations of leather; animal skins, hides; trunks and travelling bags

Frequently Asked Questions

How many trademarks does Yanyan Shi have?

Yanyan Shi has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending, 3 cancelled.

What trademark classes does Yanyan Shi file in?

Yanyan Shi files trademarks across 2 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 18 (Leather Goods). Class 25 covers clothing, footwear, headgear.

What are Yanyan Shi's most well-known trademarks?

Yanyan Shi's registered trademark portfolio includes well-known marks such as IEMATOZ, REAMPHY, and TSMNZMU. These are among 3 currently registered trademarks in the portfolio.

What is Yanyan Shi's trademark registration success rate?

Yanyan Shi has a 50% trademark registration rate, with 3 out of 6 resolved applications resulting in successful registration. Currently, 1 application is pending review.